J.P. Morgan Healthcare Conference

Pharma

Bayer projects $3B sales potential each for Kerendia, Nubeqa

Bayer raised its peak sales projection for its heart medication Kerendia and prostate cancer treatment Nubeqa to 3 billion euros ($3.2 billion) each.
Kevin Dunleavy Jan 10, 2023 4:20pm

Takeda expands manufacturing in preparation for Qdenga launch

Jan 10, 2023 10:17am

Eylea sales disappoint in Q4, Regeneron says its a 'blip'

Jan 9, 2023 3:15pm

Sayonara, San Francisco. #JPM22 is moving to virtual

Dec 15, 2021 9:53am

GlaxoSmithKline CEO reshuffles 40% of management team

Jan 9, 2018 10:10am

AbbVie chief joins the 10% price-hike pledge

Jan 12, 2017 9:53am